Form 4: Mirum Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Peter Radovich, President and COO of Mirum Pharmaceuticals, sold 1,998 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Peter Radovich, the President and COO of Mirum Pharmaceuticals, sold 1,998 shares of common stock on January 7, 2025.
• The sale was executed at a price of $42.8153 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Radovich directly owns 27,015 shares of Mirum Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: This is a routine transaction and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the pharmaceutical industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar transactions by executives at other firms.
• The sale of 1,998 shares is not unusual for an executive at this level.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is generally not considered a significant event.

Key Dates

Keywords

Mirum Pharmaceuticals, Peter Radovich, stock sale, insider trading, Form 4, executive compensation, restricted stock units, tax obligations